Topic: United States
CHICAGO (Reuters) - GlaxoSmithKline's diabetes drug Avandia was no riskier to the heart than a rival, U.S. researchers said on Tuesday, a finding that contradicts earlier studies and adds new fodder to the roiling debate over the drug's safety. The study of ...
NEW YORK (Reuters Health) - Nearly 30 percent of U.S. diabetics over the age of 40 may have a diabetes-related eye disorder, with 4 percent of this population affected severely enough that their vision is threatened, suggests a new study. The condition, ...
AstraZeneca pays $198 million to settle US lawsuits over antipsychotic drugAstraZeneca PLC says it has paid around $198 million to settle U.S. lawsuits over its antipsychotic drug Seroquel. AstraZeneca said Monday it has paid out to around 17,500 claimants regarding allegations the ...
NEW YORK (Reuters Health) - Pregnant women with a history of pregnancy-related diabetes, also called gestational diabetes, have a good chance of developing the condition again, suggests a large new study. Researchers found that the risk of having gestational diabetes during a ...
Bristol-Myers expected to focus on drug research progress, approval prospects in 2Q reportDrugmaker Bristol-Myers Squibb Co. is expected to focus on a raft of recent positive research data and plans to seek approval for several drugs when it reports its second-quarter results ...
Product recalls: dietary supplementsThe following recalls have been announced: _ Good Health Inc., of Canutillo, Texas, is recalling select lots of the dietary supplement Vialipro because they could contain a compound that is chemically similar to the erectile dysfunction drug sildenafil. This ...
A majority of members of a key advisory committee have recommended that the US government allow diabetes drug Avandia to stay on the market with greater restrictions on its sale. Most of the panel's members agreed that the drug increases the risk ...
PARIS (Reuters Life!) - A former Royal Air Force pilot with diabetes is preparing to break another record by touching down in all 50 U.S. states and show that the disease is no obstacle for enthusiasts who dream of flying. London-based Douglas ...
LONDON (Reuters) - European regulators are launching a new probe into the safety of GlaxoSmithKline Plc's diabetes pill Avandia, adding to pressure on a medicine that already faces a grilling from U.S. experts next week. The European Medicines Agency (EMA) said on ...
CHICAGO (Reuters) - Aggressively controlling blood pressure in diabetics with heart disease may do little to reduce their risks of dying early and may even be dangerous, U.S. researchers said on Tuesday. They found that using a combination of drugs to keep ...